πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 160 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9206183

Substituted pyrazolo[1,5-a]pyridines as JAK inhibitors

Almirall, S.A. Β· Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9132122

1β€²,3β€²-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1β€²H-[1,4β€²]bipyridinyl-2β€²-ones

Addex Pharma, S.A. Β· Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9133200

Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as JAK inhibitors

Almirall, S.A. Β· Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9114138

1β€²,3β€²-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1β€²H-[1,4β€²] bipyridinyl-2β€²-ones

Addex Pharma, S.A. Β· Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9108918

Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl

Almirall, S.A. Β· Granted Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9107912

Methods for concomitant treatment of theophylline and febuxostat

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9085577

7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modu

Addex Pharma, S.A. Β· Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9073907

Thiazoles derivatives and their use as positive allosteric modulators of metabotropic glut

Addex Pharma, S.A. Β· Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9067891

1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modula

Addex Pharma, S.A. Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056100

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9034311

Pyridin-2(1 H)-one derivatives as JAK inhibitors

Almirall, S.A. Β· Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8946205

1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators

Addex Pharma, S.A. Β· Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8937060

1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention

Addex Pharma, S.A. Β· Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8906939

3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives

Addex Pharma, S.A. Β· Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8883826

Alkynyl derivatives as modulators of metabotropic glutamate receptors

Addex Pharma, S.A. Β· Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8865728

Combinations comprising methotrexate and DHODH inhibitors

Almirall, S.A. Β· Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8841333

Methods for treating nephrolithiasis

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8841323

1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modul

Addex Pharma, S.A. Β· Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8802699

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8785486

Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGlu

Addex Pharma, S.A. Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8785491

Pharmaceutical compositions and methods for treating age-related macular degeneration with

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8779129

Triazinedione derivatives as GABAB receptor modulators

Addex Pharma, S.A. Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8772288

Substituted spiro[cycloalkyl-1,3β€²-indo]-2β€²(1β€²H)-one derivatives and their use as P38 mitog

Almirall, S.A. Β· Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8765717

Meloxicam and glucosamine formulation and uses thereof

Monte Verde S.A. Β· Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted